Merck KGaA Names Garijo to Run Serono Biotechnology Unit

Merck KGaA promoted a former Sanofi executive to run its pharmaceutical business as it seeks to overcome competition and drug development setbacks that have dragged down sales.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.